rs200050729

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP6

The NM_032043.3(BRIP1):​c.380-17T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000287 in 1,602,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00036 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00028 ( 0 hom. )

Consequence

BRIP1
NM_032043.3 intron

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:11

Conservation

PhyloP100: 0.0940

Publications

1 publications found
Variant links:
Genes affected
BRIP1 (HGNC:20473): (BRCA1 interacting helicase 1) The protein encoded by this gene is a member of the RecQ DEAH helicase family and interacts with the BRCT repeats of breast cancer, type 1 (BRCA1). The bound complex is important in the normal double-strand break repair function of breast cancer, type 1 (BRCA1). This gene may be a target of germline cancer-inducing mutations. [provided by RefSeq, Jul 2008]
BRIP1 Gene-Disease associations (from GenCC):
  • familial ovarian cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Fanconi anemia
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • Fanconi anemia complementation group J
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hereditary breast carcinoma
    Inheritance: AD Classification: STRONG, LIMITED, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • colorectal adenoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP6
Variant 17-61849273-A-T is Benign according to our data. Variant chr17-61849273-A-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 136577.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BRIP1NM_032043.3 linkc.380-17T>A intron_variant Intron 4 of 19 ENST00000259008.7 NP_114432.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BRIP1ENST00000259008.7 linkc.380-17T>A intron_variant Intron 4 of 19 1 NM_032043.3 ENSP00000259008.2

Frequencies

GnomAD3 genomes
AF:
0.000356
AC:
54
AN:
151862
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000986
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00105
Gnomad FIN
AF:
0.000660
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000280
Gnomad OTH
AF:
0.000481
GnomAD2 exomes
AF:
0.000406
AC:
98
AN:
241600
AF XY:
0.000359
show subpopulations
Gnomad AFR exome
AF:
0.000129
Gnomad AMR exome
AF:
0.000851
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000112
Gnomad FIN exome
AF:
0.000472
Gnomad NFE exome
AF:
0.000370
Gnomad OTH exome
AF:
0.000511
GnomAD4 exome
AF:
0.000279
AC:
405
AN:
1450020
Hom.:
0
Cov.:
30
AF XY:
0.000270
AC XY:
195
AN XY:
721316
show subpopulations
African (AFR)
AF:
0.000121
AC:
4
AN:
32952
American (AMR)
AF:
0.00103
AC:
45
AN:
43510
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25858
East Asian (EAS)
AF:
0.0000759
AC:
3
AN:
39502
South Asian (SAS)
AF:
0.000416
AC:
35
AN:
84044
European-Finnish (FIN)
AF:
0.000510
AC:
27
AN:
52954
Middle Eastern (MID)
AF:
0.000185
AC:
1
AN:
5400
European-Non Finnish (NFE)
AF:
0.000244
AC:
270
AN:
1105904
Other (OTH)
AF:
0.000334
AC:
20
AN:
59896
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000355
AC:
54
AN:
151980
Hom.:
0
Cov.:
32
AF XY:
0.000363
AC XY:
27
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41508
American (AMR)
AF:
0.000985
AC:
15
AN:
15228
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3462
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5182
South Asian (SAS)
AF:
0.00105
AC:
5
AN:
4774
European-Finnish (FIN)
AF:
0.000660
AC:
7
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.000280
AC:
19
AN:
67918
Other (OTH)
AF:
0.000476
AC:
1
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000106
Hom.:
0
Bravo
AF:
0.000370
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:11
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:5
-
Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 24, 2017
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 06, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Uncertain:2Benign:1
Oct 01, 2024
Molecular Diagnostics Laboratory, Catalan Institute of Oncology
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PVS1_Supporting (RNA) BRIP1 c.380-17T>A is an intronic variant located close to a canonical splice site. This variant is found in 103/258690 alleles at a frequency of 0.039% in the gnomAD v2.1.1 database, non-cancer dataset. The SpliceAI algorithm predicts that the variant impairs the splicing acceptor site of exon 5 (delta score = 0.24). An internal RNA assay with primers annealing exons 3 and 6 in cultured lymphocytes from a carrier patient in the presence of NMD-inhibition was performed. It showed that this variant abolishes the natural donor splice site of exon 5, causing the skipping of this exon (r.380_507del), which is predicted to lead to a truncated protein triggering NMD (p.Ser128*). This transcript was also detected in controls, although at a lower proportion compared to the patient sample. Quantification of transcript proportions using a tag-SNP could not be performed (PVS1_Supporting (RNA), unpublished data). It has been reported in the ClinVar database (1x Uncertain Significance; 9x Likely benign; 1x Benign) and in the LOVD database (4 likely benign) with conflicting interpretations of pathogenicity. Based on currently available information, the variant c.380-17T>A should be considered an uncertain significance variant. -

Jun 05, 2021
Sema4, Sema4
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Jul 22, 2015
Color Diagnostics, LLC DBA Color Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Jan 14, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Breast and/or ovarian cancer Benign:1
Jun 05, 2023
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial cancer of breast;C1836860:Fanconi anemia complementation group J Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial cancer of breast Benign:1
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.6
DANN
Benign
0.38
PhyloP100
0.094
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.24
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.24
Position offset: -17

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200050729; hg19: chr17-59926634; API